Gum grafting is an established mucogingival surgical therapy categorized under periodontics. The core clinical objective is to reconstruct lost or inadequate attached gingiva—the dense, collagen-rich tissue that anchors to periosteum and shields underlying alveolar bone. By transferring autologous tissue harvested from the palate or utilizing acellular dermal matrices and recombinant growth factors, clinicians rebuild the structural perimeter around affected teeth or dental implants. This intervention halts margin recession, insulates exposed root dentin, improves plaque control access, and optimizes long-term tooth preservation.

The patient receives localized infiltration anesthesia to fully numb the donor and recipient surgical sites. The periodontist prepares the recipient site by executing precise partial-thickness or full-thickness incisions, creating an envelope or advanced flap while thoroughly debriding and smoothing the exposed root dentin. If autogenous donor tissue is chosen, the clinician harvests a subepithelial connective tissue graft or free gingival graft from the hard palate, followed by primary closure or placement of a collagen dressing over the palatal wound. The harvested or allogeneic graft tissue is meticulously positioned over the exposed root surface and secured to the adjacent papillae with fine microsurgical sutures (typically 6-0 to 7-0 gauge). The overlying tissue flap is then positioned and sutured to cover the graft, ensuring optimal microvascular contact and vascular stabilization.

Gingival grafting offers several clinically verified benefits. According to the European Federation of Periodontology (EFP) clinical practice guidelines (Sanz et al., 2020), successful soft tissue grafting yields predictable root coverage, significant gains in clinical attachment level, and substantial widening of keratinized tissue. Treatment reduces root hypersensitivity by physically insulating open dentinal tubules. Furthermore, establishing a firm band of attached gingiva creates a stable seal that simplifies daily plaque removal, stabilizes the marginal tissue against muscle pull, and reduces long-term risk of progressive periodontal destruction.

Initial healing of the superficial tissue occurs within 10 to 14 days following surgery. During the first 48 hours, patient management focuses on controlling localized swelling and microvascular clot stabilization. Soft diets and specialized antiseptic rinses (such as chlorhexidine gluconate 0.12%) are maintained for two to three weeks to avoid mechanical displacement of the graft. Complete vascular re-integration and functional maturation of the transplanted connective collagen network occur across 3 to 6 months post-surgery.

Gum grafting addresses localized or generalized gingival recession, characterized by apical displacement of the marginal tissue edge. Specific clinical indications include exposure of root dentin leading to acute hypersensitivity, insufficient width of keratinized attached gingiva (<2 mm), progressive attachment loss, anatomical mucogingival deformities, aesthetic concerns involving asymmetrical tooth length, and soft-tissue deficiency surrounding dental implants (peri-implant mucositis or thin peri-implant phenotype).

Pre-operative preparation requires a complete clinical examination, including full-mouth periodontal probing, Cairo recession classification, and radiographies to evaluate interdental bone height. Patients must achieve high oral hygiene performance, ideally demonstrating an O'Leary plaque score under 20%. Any active periodontal disease or localized gingival inflammation must be fully treated prior to surgery. Patients are advised to stop smoking at least two to four weeks before the procedure to optimize microvascular healing, and hold non-steroidal anti-inflammatory drugs or anti-platelet agents as directed by their primary care physician.

Common and mild post-operative effects include localized discomfort, minor swelling, light bleeding from the palatal donor site, and temporary tissue discoloration. Uncommon risks involve partial graft necrosis, suture premature release, delayed wound healing, localized surgical site infection, and temporary sensory alteration of the greater palatine nerve. Rare and serious complications include complete graft failure, persistent paresthesia or numbness of the palatal mucosa, severe post-operative hemorrhage, and extensive tissue sloughing.

The patient journey begins with a comprehensive periodontal evaluation, including digital probing depth charting, keratinized tissue measurement, and radiographic assessment of interdental bone levels. Once candidacy is confirmed, pre-surgical decontamination removes plaque and calculus from target surfaces. On procedure day, local anesthesia renders the oral tissues completely numb. The surgeon prepares a recipient bed at the recession site, secures the graft tissue using delicate microsurgical sutures, and applies protective dressings as needed. Initial tissue integration occurs within 7 to 14 days, during which strict soft-food and oral hygiene protocols are observed. Complete histologic maturation and cellular remodeling continue over 6 to 12 months, supported by routine periodontal maintenance visits.